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Melanoma is widely known as the most lethal of allskin cancers, and pulmonary metastases are themost common presentation of advanced disease.1Melanoma of the eye, oral mucosa, genital and
perineal areas, subungual and plantar surfaces, scalp, and palms
are described, and although rare, they together make up about 10%
of melanomas.2 Primary pulmonary melanoma is the rarest type of
visceral melanoma: only 20 cases have been previously reported in
the English literature. We describe the case of a patient in whom
a primary melanoma of the bronchus was diagnosed and radically
resected, and we discuss the cause and outcome of this rare
pathology.
Clinical Summary
A 55-year-old white male smoker (40 pack-years) was referred to
us for an endobronchial lesion discovered after complaints of chest
pain, cough, and hemoptysis (Figure 1). Bronchoscopy revealed a
large polylobulated lesion originating from the intermediate bron-
chus; histology at bronchial biopsy revealed a malignant mela-
noma. A preoperative brain and abdomen computed tomographic
scan did not show any pathologic lesion. A thorough clinical
examination of the body was performed by an experienced der-
matologist: 2 suspect skin lesions (the first in the anterior left
hemithorax and the second in the ipsilateral arm) were resected,
but histology showed normal dermal nevi in both lesions. The
patient underwent an accurate evaluation of other sites at which
melanoma occasionally might occur: no oral and nasopharyngeal
mucosa, anal and rectal mucosa, or eye lesions were detected.
Furthermore, no family history for melanoma was documented.
The patient underwent a right posterolateral thoracotomy, and a
right pneumonectomy was performed; limited resection (sleeve)
was not feasible because of tumor site and size and the high risk of
positive margins (Figure 2). Mediastinal and hilar lymphadenec-
tomy was performed. Grossly, the lesion was polilobulated and
light red in color, measuring 3.2  2 cm (Figure 3). The pleural
surface, the lung, and all resected lymph nodes were free of tumor.
Histologically, the tumor was submucosal, without involve-
ment of the bronchial cartilage. The tumor grew in a lobar pattern,
and the neoplastic cells showed an epithelioid feature, with large
cytoplasm, giant nuclei, prominent nucleoli, and numerous mitotic
figures (Figure 4). Some cells showed cytoplasmic granular brown
pigment. Immunohistochemistry showed strongly positive cyto-
plasmic staining of tumor cells with antibodies to S-100 protein
(polyclonal antibody, 1:3500; Dako, Glostrup, Denmark) and
HMB-45 (1:30; Biogenex, San Ramon, Calif; Figure 5). No stain-
ing was observed in the bronchial mucosa, and a diagnosis of
malignant melanoma was thus confirmed (Table 1).
The postoperative course was uneventful, and the patient was
discharged from the hospital in good general condition. Adjuvant
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Figure 1. Thoracic computed tomographic scan showing an en-
dobronchial lesion of the bronchus intermedius.
Figure 2. Gross specimen of the resected right lung with an
endobronchial neoplastic lesion, which originates within the
bronchus intermedius.
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chemotherapy was scheduled, and the patient is alive and free of
disease 14 months after the treatment.
Discussion
Primary pulmonary melanoma is exceedingly rare: only 20 cases
have been previously reported in the English-language literature.3
Malignant melanoma represents the most common cause of death
caused by skin neoplasm; in case of advanced disease, the lung is
a common site of distant metastases. When the lung is involved, a
metastatic pattern appears as a solitary pulmonary nodule, a pos-
sible cause of misinterpretation as a primary lung cancer. Allen
and Drash4 proposed 3 criteria to distinguish primary pulmonary
melanoma from metastatic disease: junctional change with nesting
of malignant cells beneath the bronchial epithelium, invasion of
the bronchial epithelium in an area without epithelial ulceration,
and demonstration of melanoma beneath the aforementioned
changes. A correct diagnosis of primary pulmonary melanoma
requires a thorough clinical evaluation of the patient to rule out
occult sites of melanoma.
Accurate skin, eye, nasopharyngeal and oral mucosa, and ano-
rectal mucosa examination is mandatory because these sites are
occasionally the source of occult melanomas. Jensen and Egedorf5
proposed clinical criteria for the diagnosis of primary pulmonary
melanoma: no previously removed pigmental skin tumors; no
demonstrable melanomas in other organs at surgical intervention
because the pulmonary lesion might represent a metastatic disease;
no history of resected ocular tumors; solitary pulmonary tumor,
with morphologic features compatible with those of a primary lung
tumor; and no other primary melanomas in cases in which autopsy
is available.
In the present case melanoma was not demonstrable either in
the skin or in other unusual sites after a thorough clinical exami-
nation. In addition, the gross aspect of the lesion was compatible
with an endobronchial primary lung cancer.
The development of a primary melanoma within the bronchial
tree remains controversial. Authors have hypothesized that pulmo-
nary melanoma could arise from a small number of melanoblasts
because both the pharynx and esophagus can give rise to primary
melanomas and because the esophagus and trachea have a com-
mon embryologic origin.5-8
Therefore the possibility that a malignant bronchial lung mel-
anoma is a metastasis of a regressed skin melanoma is to be
considered. In fact, malignant melanoma of the skin might spon-
taneously regress, becoming clinically unapparent and yet having
metastasized.9 Our patient had no clinically proven suspect or
resected skin lesions before the diagnosis of endobronchial mela-
noma, and no familiarity for melanoma was documented. The most
common complaints of primary pulmonary melanoma described in
the previously reported 20 patients are cough (19%), hemoptysis
(40%), postobstructive pneumonia (25%), lobar collapse or atel-
ectasis (25%), and an incidental finding on chest radiography
(30%). Our patient presented with chest pain, cough, and hemop-
tysis.
The patient was 55 years old, which is in accordance with the
mean age reported in the literature. He was white and without a
family history of melanoma. All the patients previously described
were white, and family history was documented in only 1 patient.
Our patient was a 40 pack-year cigarette smoker: of the 20 previ-
ous patients, 6 were smokers, 5 were nonsmokers, and 9 had
Figure 3. Gross specimen of the endobronchial malignant
melanoma.
Figure 4. Malignant bronchial melanoma: note the epithelioid
feature of the neoplastic cells, with large cytoplasm and giant
nuclei. (Hematoxylin and eosin, original magnification 40.)
Figure 5. Strongly positive cytoplasmic staining of malignant
cells with antibody to HMB-45 (1:30).
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undocumented smoking status.3 Endobronchial location of the
tumor is common; as Ost and colleagues3 report, in 13 patients in
whom bronchoscopy was performed, tumor detection was possible
in 8 (61.5%). In these patients the tumor was described as black or
pigmented in 4 patients and nonpigmented in 4 patients. Our
patient had a polilobulated nonpigmented lesion of the intermedi-
ate bronchus, and preoperative biopsy was effective in diagnosing
melanoma. No data have been previously reported in the literature
about the effectiveness of bronchial biopsy in a correct preopera-
tive diagnosis of the endobronchial melanoma. In some cases
bronchial biopsy detects a non–small cell carcinoma; correct di-
agnosis was obtained after the operation. Only 15 surgical proce-
dures were performed in 20 patients, according to Ost and col-
leagues’3 review of the literature: 5 pneumonectomies, 8
lobectomies, and 2 segmentectomies. We were obliged to perform
a right pneumonectomy because the site of the tumor did not allow
any other resection.
The presence of lymph node involvement at the time of the
operation did not preclude long-term survival. Ost and colleagues3
report that of 15 patients who underwent surgical resection of the
tumor, 6 (40%) had lymph node involvement documented at the
time of the operation. Of these patients, 4 experienced recurrent
disease, and 2 were free of disease at 3 and 11 years, respectively.
Our patient underwent a hilar and mediastinal lymphadenectomy:
only subcarinal lymph nodes were grossly large, black, and suspect
for metastases, but this hypothesis was not confirmed at definitive
histology.
In conclusion, the success of a radical resection with long-term
survival in 5 patients (median survival, 30 months),3 suggest that
an aggressive surgical approach is mandatory in primary pulmo-
nary melanoma. Anatomic resection is considered the treatment of
choice because segmentectomy can be complicated with recur-
rence and with poor survival. Hilar and mediastinal lymphadenec-
tomy is mandatory. We suggest the utility of an adjuvant chemo-
therapeutic treatment to prevent recurrences or distant metastases.
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TABLE 1. Differentiation between a primary melanoma of
the lung and a melanin-containing carcinoid according to
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 Chromogranin A 
NSE, Neuron-specific enolase; Ep Memb Antigen, epithelial membrane
antigen.
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